Time for the AAA approach? Anti-TNF, Anti-JAK, Artificial Intelligence

Chairperson: Prof. Tatsuya Atsumi

11:10-11:15

Welcome & Introduction

11:15-11:30

Part I – Artificial Intelligence
Towards an Al-improved patient pathway in RA?
Prof. Laurent Arnaud

11:30-11:45

Part II – Anti-JAK 4
Effectiveness and safety data of JAK inhibitors in real-world clinical practice
Dr Satoshi Kubo

11:45-12:00

Part III – Anti-TNF
Profile of Patients for whom Enbrel Treatment is Suitable in Our Rheumatic Center
Dr Satoshi Ito

12:00-12:15

Panel Discussions, Q&A
Summary and closing remarks